![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/67 |
(11) | Number of the document | 3359670 |
(13) | Kind of document | T |
(96) | European patent application number | 16782372.3 |
Date of filing the European patent application | 2016-10-05 | |
(97) | Date of publication of the European application | 2018-08-15 |
(45) | Date of publication and mention of the grant of the patent | 2020-05-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/055582 |
Date | 2016-10-05 |
(87) | Number | WO 2017/062513 |
Date | 2017-04-13 |
(30) | Number | Date | Country code |
201562237462 P | 2015-10-05 | US | |
201662317268 P | 2016-04-01 | US | |
201662317271 P | 2016-04-01 | US | |
201662317366 P | 2016-04-01 | US | |
201662338388 P | 2016-05-18 | US | |
201662338385 P | 2016-05-18 | US | |
201662338386 P | 2016-05-18 | US | |
201662350149 P | 2016-06-14 | US |
(72) |
HOGE, Stephen, US
CHAKRABORTY, Tirtha, US
BESIN, Gilles, US
JAIN, Ruchi, US
|
(73) |
Modernatx, Inc.,
200 Technology Square, Cambridge, MA 02139,
US
|
(54) | METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS |
METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS |